Essential Use Information

Information on inhaler treatments for asthma and COPD that contain CFCs or that do not contain CFCs (Decisions XIV/5)

Measures by Parties to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers (Decision XII/2(3))

Plans of action regarding the phase-out of domestic use of CFC-containing metered-dose inhalers (Decision XV/5(4))

CFC stocks: Information on submitted in accordance with Decision XXV/2(4), Decision XXIV/3(4),Decision XXIII/2(4) and Decision XXI/4(1)